Liu Q - Search Results

1

Visible-light-driven Ag/AgBr/ZnFe₂O₄ composites with excellent photocatalytic activity for E. coli disinfection and organic pollutant degradation.

Xu Y, Liu Q, Liu C, Zhai Y, Xie M, Huang L, Xu H, Li H, Jing J. Xu Y, et al. Among authors: liu c, liu q. J Colloid Interface Sci. 2018 Feb 15;512:555-566. doi: 10.1016/j.jcis.2017.10.077. Epub 2017 Oct 21. J Colloid Interface Sci. 2018. PMID: 29100160

2

Synthesis of zinc ferrite/silver iodide composite with enhanced photocatalytic antibacterial and pollutant degradation ability.

Xu Y, Liu Q, Xie M, Huang S, He M, Huang L, Xu H, Li H. Xu Y, et al. Among authors: liu q. J Colloid Interface Sci. 2018 Oct 15;528:70-81. doi: 10.1016/j.jcis.2018.05.066. Epub 2018 May 22. J Colloid Interface Sci. 2018. PMID: 29843064

3

PRPF19 promotes tongue cancer growth and chemoradiotherapy resistance.

He Y, Huang C, Cai K, Liu P, Chen X, Xu YI, Ming Z, Liu Q, Xie Q, Xia X, Sun Y, Luo J, Wei R. He Y, et al. Among authors: liu q, liu p. Acta Biochim Biophys Sin (Shanghai). 2021 Jul 5;53(7):893-902. doi: 10.1093/abbs/gmab059. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 33954334 Free article.

4

Design, synthesis, and biological evaluation of novel HDAC inhibitors with a 3-(benzazol-2-yl)quinoxaline framework.

Yang Y, Liu Q, Wang X, Gou S. Yang Y, et al. Among authors: liu q. Bioorg Med Chem Lett. 2023 May 15;88:129305. doi: 10.1016/j.bmcl.2023.129305. Epub 2023 Apr 26. Bioorg Med Chem Lett. 2023. PMID: 37116762

5

Design, synthesis and biological evaluation of brain targeting l-ascorbic acid prodrugs of ibuprofen with "lock-in" function.

Zhao Y, Qu B, Wu X, Li X, Liu Q, Jin X, Guo L, Hai L, Wu Y. Zhao Y, et al. Among authors: liu q. Eur J Med Chem. 2014 Jul 23;82:314-23. doi: 10.1016/j.ejmech.2014.05.072. Epub 2014 Jun 2. Eur J Med Chem. 2014. PMID: 24927052

6

Design, synthesis and biological evaluation of cinnamamide-quinazoline derivatives as potential EGFR inhibitors to reverse T790M mutation.

Zhang B, Xu Z, Liu Q, Xia S, Liu Z, Liao Z, Gou S. Zhang B, et al. Among authors: liu z, liu q. Bioorg Chem. 2021 Dec;117:105420. doi: 10.1016/j.bioorg.2021.105420. Epub 2021 Oct 12. Bioorg Chem. 2021. PMID: 34655841

7

The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma.

Liu Q, Hua S, Wang X, Chen F, Gou S. Liu Q, et al. Cancer Immunol Immunother. 2021 Feb;70(2):497-508. doi: 10.1007/s00262-020-02697-3. Epub 2020 Aug 25. Cancer Immunol Immunother. 2021. PMID: 32840656 Free PMC article.

8

Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors.

Zhang B, Liu Z, Xia S, Liu Q, Gou S. Zhang B, et al. Among authors: liu z, liu q. Eur J Med Chem. 2021 Apr 15;216:113300. doi: 10.1016/j.ejmech.2021.113300. Epub 2021 Feb 20. Eur J Med Chem. 2021. PMID: 33640672

9

Discovery of 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol Derivatives as Glutathione Transferase Inhibitors with Favorable Selectivity and Tolerated Toxicity.

Liu Q, Liu Z, Hua W, Gou S. Liu Q, et al. Among authors: liu z. J Med Chem. 2021 Feb 11;64(3):1701-1712. doi: 10.1021/acs.jmedchem.0c02048. Epub 2021 Feb 2. J Med Chem. 2021. PMID: 33529017

10

Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathway.

Liu Q, Zhang B, Wang Y, Wang X, Gou S. Liu Q, et al. Eur J Med Chem. 2022 Feb 5;229:114058. doi: 10.1016/j.ejmech.2021.114058. Epub 2021 Dec 17. Eur J Med Chem. 2022. PMID: 34954595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,379 results

Search Page

Filters